Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors for cancer treatment. Its structure enables effective binding to enzyme active sites, enhancing drug potency. Also employed in agrochemicals to improve metabolic stability and bioavailability of active ingredients. The difluoroethyl group contributes to increased lipophilicity and resistance to oxidative degradation, making it valuable in optimizing pharmacokinetic properties.